- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
HHS is reviewing all doctors' orders for monoclonal antibodies
Posted on 9/14/21 at 6:53 am
Posted on 9/14/21 at 6:53 am
LINK
A Republican lawmaker is demanding to know why the Biden administration appears to be limiting the ability of doctors to order early treatment medications for COVID-19 patients.
Rep. Chip Roy (R-Texas) on Monday sent a letter to Department of Health and Human Services Secretary Xavier Becerra inquiring about a recent change in HHS policy that limits orders and shipments of monoclonal antibody treatments to HHS-approved administration sites.
"As you know, antibody treatments such as bamlanivimab, bamlanivimab/etesevimab, and casirivimab/imdevimab were approved under Emergency Use Authorizations (EUA) and have been shown to be effective in treating COVID-19 patients," Roy wrote to Becerra.
"Providers across the country, including providers in Texas, have utilized these treatments, aiding in effective treatment of COVID-19 patients. Unfortunately, numerous doctors and healthcare professionals who serve COVID-19 patients are reportedly being denied or limited orders for these treatments by HHS," he wrote.
Monoclonal antibody (mAb) therapy is a treatment for COVID-19 that studies have shown is effective at reducing the risk of hospitalization and death for patients with mild to moderate illness who receive early treatment. The Food and Drug Administration has granted emergency use authorization for mAb therapies to treat mild to moderate COVID-19 in adults and children older than 12, and the treatment has been promoted across the ideological spectrum by figures like Dr. Anthony Fauci and Florida Gov. Ron DeSantis.
On Sept. 3, HHS announced that because of a "substantial surge" in the demand for and use of mAb treatments, the federal government would make changes to "help promote optimal and equitable use of the available supply of monoclonal antibodies."
HHS acted to temporarily limit immediate orders and shipment of mAb treatments "only to administration sites with HHSProtect accounts and current utilization reporting." The agency also announced that it would review "all orders" by doctors for "alignment with utilization."
Roy wrote that these changes appear "appeared to have an immediate effect on the ability to expeditiously care for and treat COVID-19 patients."
Roy's letter asks the department to clarify whether there is a current or expected shortage of monoclonal antibody treatments in the U.S. Noting that HHS said the change was "temporary," Roy also asked, "When does HHS plan to revert to normal procedures for ordering these antibody treatments?"
In a statement to TheBlaze, Roy slammed the Biden administration for "impeding on providers' ability to best serve their patients."
"The last thing HHS should be doing is impeding on providers' ability to best serve their patients, especially during the COVID-19 pandemic," said Roy. "This recent HHS order will further prevent doctors from being able to treat their patients and prevent their patients from receiving the care they need when they need it. The federal government should not be in the business of dictating healthcare; the American people deserve answers on why and under which authority HHS made this decision."
A Republican lawmaker is demanding to know why the Biden administration appears to be limiting the ability of doctors to order early treatment medications for COVID-19 patients.
Rep. Chip Roy (R-Texas) on Monday sent a letter to Department of Health and Human Services Secretary Xavier Becerra inquiring about a recent change in HHS policy that limits orders and shipments of monoclonal antibody treatments to HHS-approved administration sites.
"As you know, antibody treatments such as bamlanivimab, bamlanivimab/etesevimab, and casirivimab/imdevimab were approved under Emergency Use Authorizations (EUA) and have been shown to be effective in treating COVID-19 patients," Roy wrote to Becerra.
"Providers across the country, including providers in Texas, have utilized these treatments, aiding in effective treatment of COVID-19 patients. Unfortunately, numerous doctors and healthcare professionals who serve COVID-19 patients are reportedly being denied or limited orders for these treatments by HHS," he wrote.
Monoclonal antibody (mAb) therapy is a treatment for COVID-19 that studies have shown is effective at reducing the risk of hospitalization and death for patients with mild to moderate illness who receive early treatment. The Food and Drug Administration has granted emergency use authorization for mAb therapies to treat mild to moderate COVID-19 in adults and children older than 12, and the treatment has been promoted across the ideological spectrum by figures like Dr. Anthony Fauci and Florida Gov. Ron DeSantis.
On Sept. 3, HHS announced that because of a "substantial surge" in the demand for and use of mAb treatments, the federal government would make changes to "help promote optimal and equitable use of the available supply of monoclonal antibodies."
HHS acted to temporarily limit immediate orders and shipment of mAb treatments "only to administration sites with HHSProtect accounts and current utilization reporting." The agency also announced that it would review "all orders" by doctors for "alignment with utilization."
Roy wrote that these changes appear "appeared to have an immediate effect on the ability to expeditiously care for and treat COVID-19 patients."
Roy's letter asks the department to clarify whether there is a current or expected shortage of monoclonal antibody treatments in the U.S. Noting that HHS said the change was "temporary," Roy also asked, "When does HHS plan to revert to normal procedures for ordering these antibody treatments?"
In a statement to TheBlaze, Roy slammed the Biden administration for "impeding on providers' ability to best serve their patients."
"The last thing HHS should be doing is impeding on providers' ability to best serve their patients, especially during the COVID-19 pandemic," said Roy. "This recent HHS order will further prevent doctors from being able to treat their patients and prevent their patients from receiving the care they need when they need it. The federal government should not be in the business of dictating healthcare; the American people deserve answers on why and under which authority HHS made this decision."
Posted on 9/14/21 at 6:55 am to Crimson Wraith
quote:
equitable use of
This should terrify anyone
Posted on 9/14/21 at 6:57 am to Crimson Wraith
Whoa Black Betty
quote:
bamlanivimab
Posted on 9/14/21 at 6:59 am to Strannix
quote:
quote:
equitable use of
This should terrify anyone
AKA - not you whitey
Posted on 9/14/21 at 7:16 am to Crimson Wraith
quote:
On Sept. 3, HHS announced that because of a "substantial surge" in the demand for and use of mAb treatments, the federal government would make changes to "help promote optimal and equitable use of the available supply of monoclonal antibodies."
Welp, there it is. This must be a really effective treatment.
Posted on 9/14/21 at 7:18 am to Crimson Wraith
The US Government and pure, unadulterated evil entrenched with filth.
Posted on 9/14/21 at 7:20 am to Crimson Wraith
Democrats are truly evil
Posted on 9/14/21 at 7:22 am to Crimson Wraith
Straight out of Orwell.
Posted on 9/14/21 at 7:23 am to Ace Midnight
Guess what...they will claim there's a shortage limit it to vaccinated people.
Posted on 9/14/21 at 7:26 am to Crimson Wraith
quote:Thats the Lefts goal. All of this is a feature to them.
The federal government should not be in the business of dictating healthcare;
Posted on 9/14/21 at 7:27 am to eng08
quote:
equitable use of
This should terrify anyone
AKA - not you whitey
More likely not you Red state resident who voted for Trump.
Posted on 9/14/21 at 7:47 am to udtiger
would not surprise me. i dont think vaccinated people can even give plasma for these treatments. so the unvaxxed ones who gave the plasma wont be the ones able to receive it.
Posted on 9/14/21 at 7:50 am to SLafourche07
quote:
Whoa Black Betty
quote:
bamlanivimab
I know it's early, but I feel safe in calling it. You win the Internet today!
Posted on 9/14/21 at 7:50 am to Crimson Wraith
HHS going to be used as a political hammer and progstains say nothing because they like hammers when it benefits their evil.
Posted on 9/14/21 at 7:55 am to Crimson Wraith
quote:
Unfortunately, numerous doctors and healthcare professionals who serve COVID-19 patients are reportedly being denied or limited orders for these treatments by HHS
This is scary. AMA needs to step up and start fighting for their patients. Bureaucrats have no business meddling in Medical practices.
Posted on 9/14/21 at 8:03 am to Crimson Wraith
quote:
"As you know, antibody treatments such as bamlanivimab, bamlanivimab/etesevimab, and casirivimab/imdevimab were approved under Emergency Use Authorizations (EUA) and have been shown to be effective in treating COVID-19 patients," Roy wrote to Becerra.
Bamlanivimab was revoked back in April because the variants were very resistant to it.
The other two seem to be ok but also have reduced effectiveness so they are directing those to states with lower variant numbers.
None of this affects Regeneron which appears to be the most effective.
idse.net
Posted on 9/14/21 at 8:08 am to mmcgrath
quote:
they are directing those to states with lower variant numbers.
You mean variants under 90%?
quote:
The highly transmissible delta variant now accounts for nearly 99 percent of COVID-19 cases in the U.S., according to CDC data.
quote:
August 25th, 2021
LINK
Who told you that pile of shite you posted?
Posted on 9/14/21 at 8:08 am to SLafourche07
quote:
Whoa Black Betty
quote:
bamlanivimab
HAHAHAHAHA
I spit coffee. You win.
Posted on 9/14/21 at 8:10 am to Crimson Wraith
Isn't Florida, therefore DeSantis, kicking arse with these treatments? The Federal Govt can't let Florida/DeSantis succeed so they will slowdown/limit the supply. They can't let Florida win.
Popular
Back to top
Follow TigerDroppings for LSU Football News